American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

Transplant PRN Focus Session — Check Yourself Before You Wreck Yourself: Management of ICIs in Solid Organ Transplant

Sunday, October 18, 2026 from 4:00 p.m. to 5:30 p.m. MDT at Salt Palace Convention Center - Ballroom J

Available for 1.50 hours of CPE credit
Activity Type: A Knowledge-Based Activity

This session will enhance pharmacists’ knowledge of immune checkpoint inhibitors (ICIs), including their oncologic use and key considerations during the pre- and post-transplantation phases. As the role of ICIs in various cancers continues to evolve, it is essential for pharmacists to understand the impact of these agents on transplant care to provide informed recommendations to the multidisciplinary team. As medication experts, pharmacists play an important role in assessing the risks and benefits of ICIs in the phases of the transplant process. Learners will have the opportunity to engage with presenters through real-world examples along with audience response and multiple-choice questions to illustrate the challenges and successes in this emerging area of pharmacotherapy.​ 

Learning Objectives

1. Examine immunologic mechanisms and adverse effects associated with immune checkpoint inhibitor use.  

2. ​​​Summarize the role of immune checkpoint inhibitor therapy in the pre- and-post transplant setting for hepatocellular carcinoma and skin cancer, respectively.​​  

3. ​​​Identify the risks associated with the use of immune checkpoint inhibitors for cancer therapy in the pre- and post-transplant phases.​​  

4. Outline an assessment and management plan for the consideration of immune checkpoint Inhibitor use in the pre- and post-transplant setting.​​  

Marissa M. Brokhof, Pharm.D., BCPS, BCTXP
Moderator:Marissa M. Brokhof, Pharm.D., BCPS, BCTXP

An Overview of Immune Checkpoint Inhibitors from the Drug Information Experts​

4:00 p.m. to 4:25 p.m.
Kristen D. Belfield, Pharm.D., BCTXP
Speaker:Kristen D. Belfield, Pharm.D., BCTXP

Revolutionizing Cancer Treatment: The Use of Immune Checkpoint Inhibitors

4:25 p.m. to 4:50 p.m.
Abbie D. Leino, Pharm.D., Ph.D., BCPS
Speaker:Abbie D. Leino, Pharm.D., Ph.D., BCPS

The Role of the Pharmacist: Managing Immune Checkpoint Inhibitor Use Pre- and Post-Transplant​

4:50 p.m. to 5:15 p.m.
Mary Leick, Pharm.D., BCPS, BCTXP
Speaker:Mary Leick, Pharm.D., BCPS, BCTXP

Question & Answer Panel

5:15 p.m. to 5:30 p.m.